Manufacture of basic pharmaceutical substances and medicines and other (PKD division 21)2007
Industry statistics (2025)
Number of companies
Companies
8,172
Companies (primary PKD)
646
Companies with financials
330
Business turnover
Legal structure
Legal formShare of companiesNumber of companies
- Sp. z o.o.72.4%468
- Sp. j.7.7%50
- JDG7.6%49
- S.A.6.3%41
- Sp. k.2.0%13
- P.S.A.1.5%10
- Cooperative0.9%6
- Other0.8%5
- Foundation0.5%3
Financial results
Median revenue
Ranking
Median revenue compared with other PKD codes.
Top companies by revenue
| # | Company | Legal form | Revenue | Net profit |
|---|---|---|---|---|
| 1 | S.A. | USD 1.25bn | USD 236.49m | |
| 2 | S.A. | USD 615.32m | USD 16.99m | |
| 3 | S.A. | USD 539.49m | USD 53.86m | |
| 4 | sp. z o.o. | USD 527.04m | USD 77.39m | |
| 5 | sp. z o.o. | USD 300.66m | USD 59.18m | |
| 6 | sp. z o.o. | USD 245.99m | USD 33.23m | |
| 7 | S.A. | USD 159.45m | USD 6.68m | |
| 8 | sp. z o.o. | USD 142.78m | USD 34.11m | |
| 9 | S.A. | USD 119.08m | USD 4.98m | |
| 10 | sp. z o.o. | USD 112.36m | USD 2.95m |
Fastest-growing companies
| # | Company | Legal form | Revenue | Y/Y growth |
|---|---|---|---|---|
| 1 | sp. z o.o. | USD 101.19m | +333.1% y/y | |
| 2 | sp. z o.o. | USD 47.06m | +92.4% y/y | |
| 3 | sp. z o.o. | USD 3.81m | +83.9% y/y | |
| 4 | sp. z o.o. | USD 7.35m | +80.7% y/y | |
| 5 | sp. z o.o. | USD 1.81m | +66.3% y/y | |
| 6 | sp. z o.o. | USD 1.35m | +58.6% y/y | |
| 7 | sp. z o.o. | USD 21.37m | +57.8% y/y | |
| 8 | sp. z o.o. | USD 4.24m | +54.9% y/y | |
| 9 | sp. z o.o. | USD 1.97m | +50.5% y/y | |
| 10 | sp. z o.o. | USD 2.14m | +49.3% y/y |
Stock market
No companies from this industry are listed.
PKD codes in division 21
FAQ
The primary industry for 646 companies is manufacture of basic pharmaceutical substances and medicines and other. 330 entities have filed financial statements.
In 2024, 23 new companies with PKD 21 were registered. In all of 2023, there were 22 such companies.
In 2024, 2 companies with PKD 21 were deregistered. In all of 2023, there were 2 such companies.
In 2025, the median revenue for PKD 21 was USD 909.97k and the mean revenue was USD 27.46m, based on 238 financial statements. Averages and medians include only companies that file financial statements, excluding sole proprietorships.
Yes, in 2025, the median net profit was USD 28.21k, an improvement on 2024 (USD 8.23k). Among all 626 PKD divisions in Poland, it ranks 250th, putting it in the top 40%.
The most common legal form for PKD 21 is sp. z o.o., used by 468 companies in this industry (72.4% of the total). In second place is sp. j. (50 companies, 7.7%), and in third place – a sole proprietorship (49 companies, 7.6%).










